BDX (STOCKS)
Becton, Dickinson and Co.
$178.809000
-4.771000 (-2.60%)
Prev close: $183.580000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas E. Polen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $53,462.59M
- Employees
- 74,000
- P/E (TTM)
- 55.37
- P/B (TTM)
- 2.05
- Dividend Yield
- 228.24%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
5
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q3)
|
$3.23 | $3.17 | +0.0572 | +1.80% |
|
Mar 2026 (Q2)
|
$2.90 | $2.80 | +0.0973 | +3.47% |
|
Dec 2025 (Q1)
|
$2.91 | $2.84 | +0.0695 | +2.45% |
|
Sep 2025 (Q4)
|
$3.96 | $3.96 | -0.0018 | -0.05% |
Financial Statements
| Revenues | $23.25B |
| Benefits Costs and Expenses | $21.29B |
| Cost Of Revenue | $12.34B |
| Costs And Expenses | $20.77B |
| Gross Profit | $10.91B |
| Operating Expenses | $8.15B |
| Selling, General, and Administrative Expenses | $5.55B |
| Research and Development | $1.37B |
| Other Operating Expenses | $1.31B |
| Operating Income/Loss | $2.40B |
| Income/Loss From Continuing Operations After Tax | $1.72B |
| Income/Loss From Continuing Operations Before Tax | $1.96B |
| Income/Loss From Discontinued Operations Net Of Tax | -$706.00M |
| Income Tax Expense/Benefit | $231.00M |
| Net Income/Loss | $941.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $941.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $941.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.32 |
| Diluted Earnings Per Share | $3.32 |
| Basic Average Shares | 557,577,000 |
| Diluted Average Shares | 559,608,000 |
| Assets | $50.73B |
| Current Assets | $8.14B |
| Inventory | $3.32B |
| Other Current Assets | $4.82B |
| Noncurrent Assets | $42.59B |
| Fixed Assets | $6.08B |
| Other Non-current Assets | $36.51B |
| Liabilities | $26.32B |
| Current Liabilities | $9.40B |
| Noncurrent Liabilities | $16.91B |
| Equity | $24.42B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $24.42B |
| Liabilities And Equity | $50.73B |
| Net Cash Flow From Operating Activities | $3.26B |
| Net Cash Flow From Operating Activities, Continuing | $3.96B |
| Net Cash Flow From Operating Activities, Discontinued | -$696.00M |
| Net Cash Flow From Investing Activities | -$1.10B |
| Net Cash Flow From Investing Activities, Continuing | -$1.15B |
| Net Cash Flow From Financing Activities | -$2.11B |
| Net Cash Flow From Financing Activities, Continuing | -$2.10B |
| Exchange Gains/Losses | $7.00M |
| Net Cash Flow | $65.00M |
| Net Cash Flow, Continuing | $701.00M |
| Net Cash Flow, Discontinued | -$644.00M |
| Comprehensive Income/Loss | $1.11B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.11B |
| Other Comprehensive Income/Loss | $164.00M |